Oct 13 (Reuters) - The U.S. government has entered an
agreement with Danaher Corp-owned Cytiva to expand the
manufacturing of products that are essential for producing
COVID-19 vaccines, the U.S. Department of Health and Human
Services said on Tuesday.
Under the deal, Cytiva will receive about $31 million to
scale up manufacturing of vaccine-related products.
(Reporting By Mrinalika Roy in Bengaluru; Editing by Devika